19
May 23
Pfizer Renewed as HKAPI Full Member
HKAPI is pleased to announce that Pfizer has renewed as full member of the Association.
17
May 23
HKAPI joined the Panel at 3rd ASGH Project Pitching Sessions
We are delighted to announce that our Senior Executive Director, Ms. Sabrina Chan, was invited by the Hong Kong Trade Development Council (HKTDC) to participate in the 3rd Asia Summit on Global Health (ASGH) as one of the panelists for the Project Pitching Sessions.
13
Apr 23
Medical Representatives’ Training Programme 2023
We are thrilled to announce the commencement of the HKAPI Medical Representatives Training Programme 2023. This programme has been providing comprehensive training to medical representatives since the 1980s and has […]
05
Apr 23
Appointment of New Board Members
HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
22
Mar 23
Successful AGM of the Hong Kong Association of the Pharmaceutical Industry
We are delighted to announce that the Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry was held successfully on 22nd March 2023.
17
Mar 23
HKAPI Representatives visited Nan Sha, Guangdong
Representatives from the HKAPI GBA task force recently participated in a two-day trip to Nan Sha, Guangdong, on March 16-17.
11
Mar 23
Ms Sabrina Chan shared her insights on PGx trend in a recent webinar
Ms Sabrina Chan, Senior Executive Director of HKAPI, was invited to be one of the speakers at a recent webinar about pharmacogenetics on 11 March.
01
Mar 23
Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry
Over 30 members attended the seminar on-site, and 50 joined virtually.
01
Mar 23
Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry
In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.
13
Feb 23
Briefing session for Regulatory Intelligence Survey
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
